Industry and patient representatives debated how the FDA should regulate generative AI in medical devices and address new ...

From M&A and tariffs to new health leaders, here are the top issues for the medtech industry to watch when President-elect ...

Nixon, an Intuitive veteran, said Capstan is focused primarily on mitral and tricuspid treatment, where it sees “significant ...

In January, Endoquest’s system was accepted into the FDA’s Safer Technologies Program for devices expected to improve the ...

Rates of postoperative complications, readmissions and death were lower after robotic surgeries than laparoscopic and open ...

Under new leadership, the patient monitoring company is allocating resources to fewer projects as it focuses on market ...

Labcorp continued its streak of hospital lab purchases with a deal that will expand its testing capabilities to communities ...

Brian Thompson’s death on Wednesday set off a flood of darkly celebratory social media posts offset by solemn remembrances ...

The job cuts in Memphis, Tennessee, are part of a turnaround plan that has seen the U.K.-based medical device maker shutter ...

U.S. approval of an expanded indication for transcatheter aortic valve replacement in patients without symptoms is among the ...

Selling the assets to Italy’s GVS should help Haemonetics improve its revenue growth and profit margins, analysts said.

By using pre-determined change control plans, manufacturers can update AI-enabled devices without filing an additional FDA ...